GlassScriptPhysician profile
Larry J Payne
NPI 1366504474
$2,271.33
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $738 · 2020: $600 · 2021: $791 · 2022: $142.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $500.64 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $354.02 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $338.20 | 2019 | |
| Glaukos Corporation | $233.90 | 2019-2021 | |
| Alcon Vision LLC | $169.42 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $143.79 | 2021 | |
| Aerie Pharmaceuticals, INC. | $105.75 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $99.14 | 2020-2021 | |
| Akorn, INC. | $85.32 | 2019 | |
| Carl Zeiss Meditec, INC. | $42.68 | 2019 | |
| Horizon Therapeutics Plc | $36.72 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.22 | 2020-2021 | |
| Shire North American Group INC | $28.47 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Eyevance Pharmaceuticals LLC | $19.36 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $19.04 | 2022 | |
| Ocular Therapeutix, INC. | $15.69 | 2019 | |
| Omeros Corporation | $12.79 | 2021 | |
| Alimera Sciences, INC. | $10.78 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.